| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,871 |
26,158 |
$1.26M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,131 |
26,204 |
$988K |
| 99233 |
Prolong inpt eval add15 m |
3,185 |
1,374 |
$135K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,007 |
1,793 |
$116K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,283 |
1,234 |
$88K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,799 |
6,047 |
$86K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,945 |
1,174 |
$86K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,340 |
1,278 |
$68K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
657 |
178 |
$64K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
718 |
684 |
$55K |
| 20610 |
|
1,341 |
1,188 |
$48K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,074 |
2,821 |
$39K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
292 |
285 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,896 |
767 |
$19K |
| 99215 |
Prolong outpt/office vis |
328 |
309 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
385 |
349 |
$17K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,021 |
501 |
$17K |
| 73562 |
|
973 |
860 |
$16K |
| 99223 |
Prolong inpt eval add15 m |
258 |
201 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
498 |
463 |
$15K |
| 72100 |
|
733 |
660 |
$12K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
76 |
70 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,028 |
819 |
$10K |
| 94729 |
|
782 |
769 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
268 |
246 |
$7K |
| 94727 |
|
769 |
758 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
98 |
90 |
$7K |
| 90682 |
|
144 |
141 |
$7K |
| 73030 |
|
348 |
321 |
$5K |
| 90474 |
|
628 |
531 |
$5K |
| 87807 |
|
276 |
246 |
$3K |
| 94060 |
|
217 |
208 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
32 |
30 |
$2K |
| 90686 |
|
1,172 |
1,061 |
$2K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$2K |
| 94010 |
|
165 |
165 |
$1K |
| 90715 |
|
46 |
34 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,052 |
796 |
$933.66 |
| 72170 |
|
73 |
67 |
$917.47 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$730.26 |
| 73130 |
|
42 |
39 |
$725.21 |
| 72040 |
|
45 |
40 |
$632.63 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
125 |
112 |
$430.11 |
| 81003 |
|
271 |
222 |
$386.39 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
937 |
757 |
$343.78 |
| 95115 |
|
48 |
24 |
$278.39 |
| 73630 |
|
36 |
28 |
$222.41 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
15 |
15 |
$166.68 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
12 |
$77.30 |
| 3044F |
|
1,484 |
1,351 |
$40.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
55 |
51 |
$28.41 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
14 |
13 |
$24.21 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
45 |
37 |
$7.28 |
| 90633 |
|
297 |
264 |
$1.40 |
| 3074F |
|
8,216 |
7,641 |
$1.04 |
| 90670 |
|
1,211 |
1,117 |
$0.86 |
| 3078F |
|
6,550 |
6,091 |
$0.86 |
| 90619 |
|
16 |
15 |
$0.45 |
| 3079F |
|
2,872 |
2,748 |
$0.36 |
| 3075F |
|
940 |
892 |
$0.18 |
| 90697 |
|
33 |
29 |
$0.08 |
| 3008F |
|
18,216 |
16,545 |
$0.00 |
| 4010F |
|
1,874 |
1,674 |
$0.00 |
| 90680 |
|
602 |
546 |
$0.00 |
| 90698 |
|
115 |
112 |
$0.00 |
| 3080F |
|
24 |
24 |
$0.00 |
| 90723 |
|
25 |
24 |
$0.00 |
| 3066F |
|
84 |
76 |
$0.00 |
| 90744 |
|
25 |
25 |
$0.00 |
| 1159F |
|
23,133 |
20,731 |
$0.00 |
| 90648 |
|
136 |
132 |
$0.00 |
| 1160F |
|
19,249 |
17,283 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |
| 90710 |
|
34 |
28 |
$0.00 |
| 3077F |
|
138 |
130 |
$0.00 |
| 90685 |
|
33 |
26 |
$0.00 |